PMID: 25743846Mar 7, 2015Paper

Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival

Asian Pacific Journal of Cancer Prevention : APJCP
Arife UlasMustafa Degirmenci

Abstract

The aim of the present study was to evaluate clinicopathological characteristics of our early stage breast cancer patients who are epidermal growth factor receptor 2 (HER2) overexpressed/ amplified (HER2+), the efficacy of trastuzumab treatment and survival results. Patients with HER2- positive early stage breast cancer receiving adjuvant trastuzumab were investigated retrospectively. Clinicopathological features of 210 patients and treatment outcome were analysed. To evaluate survival rates, the Kaplan-Meier method was used. Univariate and multivariate analyses were conducted with the Cox regression model. Mean age of the patients was 51.8, 71.9% being postmenopausal. Some 37.6% of patients were node negative, and 31% had T1 tumor size and 52.4% were positive for estrogen receptor. Of 210 patients, 89.5% completed planned 52 weeks adjuvant trastuzumab treatment. The median follow up was 27.5 months (6.0-86.0 ). Relapse free survival (RFS) was 68.0 months (95% CI: 62.1-74.0) and overall survival (OS) was 74.8 months (95% CI: 69.5-80.1). The 3 year OS for all patients was 92.0% and RFS was 79.6%. During follow up, relapse was detected at the rate of 14.3%. Trastuzumab associated cardiotoxicity was found at the rate of 3.3%. In u...Continue Reading

References

Aug 30, 2000·Nature·C M PerouD Botstein
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Jul 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M SuterMartine J Piccart-Gebhart
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Nov 4, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Richard ShafferIslam Mohamed
Dec 25, 2008·Nature Clinical Practice. Oncology·Gabriella MarianiLuca Gianni
Dec 30, 2008·Breast Cancer Research and Treatment·James MansellJulie C Doughty
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc SpielmannFrédérique Penault-Llorca
Nov 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth A MittendorfAna M Gonzalez-Angulo
Dec 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paula R PohlmannRay Mernaugh
Sep 4, 2010·Breast Cancer Research and Treatment·Zsolt GabosBassam Abdulkarim
Jul 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezNorman Wolmark
Sep 6, 2012·Journal of the National Cancer Institute·Erin J Aiello BowlesUNKNOWN Pharmacovigilance Study Team
Oct 2, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I Vaz-LuisN U Lin
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Otto Metzger-FilhoMartine Piccart-Gebhart
May 18, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Cheng-Jeng TaiHung-Yi Chiou
Jan 28, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Zhen-Li ZhuKe Li
Oct 22, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezNorman Wolmark
Feb 1, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I Vaz-LuisN U Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.